Phathom Pharmaceuticals (PHAT) Profit After Tax (2018 - 2026)
Phathom Pharmaceuticals' (PHAT) quarterly Profit After Tax came in at -$30.4 million in Q1 2026, up 67.8% year-on-year from -$18.1 million in Q1 2025, and down 43.6% on a QoQ basis from -$21.1 million in Q4 2025.
Phathom Pharmaceuticals (PHAT) Profit After Tax (2018 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 9 years of Profit After Tax data on file, last reported at -$30.4 million in Q1 2026.
- On a quarterly basis, Profit After Tax rose 67.8% year-over-year to -$30.4 million in Q1 2026; TTM through Mar 2026 was -$157.3 million, a 54.51% increase from a year earlier, with the FY2025 full-year figure at -$221.2 million, up 33.82% from the prior year.
- Profit After Tax for Q1 2026 stood at -$30.4 million, down from -$21.1 million in the prior quarter.
- Over the last five years, Profit After Tax for PHAT reached as high as -$21.1 million in Q4 2025 and fell as low as -$94.3 million in Q1 2025.
- Historically, Profit After Tax has averaged -$58.0 million across 5 years, with a median of -$51.1 million in 2022.
- Across the five-year window, Profit After Tax sank 123.23% in 2024 and jumped 71.59% in 2025, its largest moves.
- Year by year, Profit After Tax stood at -$55.0 million in 2022, then sank by 44.55% to -$79.6 million in 2023, then advanced by 6.43% to -$74.5 million in 2024, then soared by 71.59% to -$21.1 million in 2025, then plunged by 43.6% to -$30.4 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$30.4 million in Q1 2026, -$21.1 million in Q4 2025, and -$30.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Phathom Pharmaceuticals | 951.79 Mn | 768.02 Mn | 46.31 Mn | -30.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.37 Mn |
| Dec 31, 2025 | -21.15 Mn |
| Sep 30, 2025 | -29.97 Mn |
| Jun 30, 2025 | -75.81 Mn |
| Mar 31, 2025 | -94.32 Mn |
| Dec 31, 2024 | -74.45 Mn |
| Sep 30, 2024 | -85.58 Mn |
| Jun 30, 2024 | -91.45 Mn |
| Mar 31, 2024 | -82.85 Mn |
| Dec 31, 2023 | -79.57 Mn |
| Sep 30, 2023 | -43.24 Mn |
| Jun 30, 2023 | -40.97 Mn |
| Mar 31, 2023 | -37.81 Mn |
| Dec 31, 2022 | -55.05 Mn |
| Sep 30, 2022 | -51.09 Mn |
| Jun 30, 2022 | -50.92 Mn |
| Mar 31, 2022 | -40.67 Mn |
| Dec 31, 2021 | -35.83 Mn |
| Sep 30, 2021 | -36.66 Mn |
| Jun 30, 2021 | -36.55 Mn |